Phuong The Nguyen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Phuong The Nguyen has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Kota Katanoda
Division of Population Data Science, National Cancer Center Institute for Cancer Control , Tokyo
33 shared publications - Tomohiro Matsuda
Division of International Health Policy Research, Institute for Cancer Control, National Cancer Center , 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045
33 shared publications - Megumi Hori
Division of Cancer Statistics Integration, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan
32 shared publications - Huy Van Nguyen
Health Innovation & Transformation Centre, Federation University Australia, Ballarat, Australia
6 shared publications Stuart Gilmour
Graduate School of Public Health, St. Luke’s International University, Tokyo, Japan
6 shared publications- Phuong Mai Le
Department of International Trials, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan
5 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Elsevier in Social Sciences & Humanities Open
- Vol. 14
Trends in the prevalence and inequalities of serious psychological distress in Japan since the COVID-19 pandemic, 2020–2025
- 19 October 2026
- Published by Elsevier in Social Sciences & Humanities Open
- Vol. 14
Open AccessTrends in the prevalence and inequalities of serious psychological distress in Japan since the COVID-19 pandemic, 2020–2025
- Open Access
- 27 July 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (10) , 2415-2425
Forecasting colorectal cancer screening in Japan: regional and sex disparities threaten national targets
Objective: To forecast prefecture-level progress toward Japan's 60% colorectal cancer (CRC) screening target by 2028 and quantify regional and sex-based disparities. Methods: We extracted CRC screening rates (ages 40–69) for all 47 prefectures from 2013 to 2022 using the Comprehensive Survey of Living Conditions. Sex-stratified Bayesian linear regression models were applied to logit-transformed rates. Prefectures were considered likely to achieve the target if the probability of ≥ 60% uptake by 2028 was ≥ 80%. Results: Nationwide coverage is projected to reach 51.9% (95% CrI 44.9–58.8%) by 2028, falling 8.1 percentage points short of the 60% target. Forty of 47 prefectures (85%) had less than a 20% posterior probability of meeting the target, and 14 were projected below 50% coverage. Only Yamagata exceeded the 80% probability threshold for the total population (probability 0.988). For men, three prefectures did (Yamagata, Yamanashi, Miyagi), versus one for women. Men outperformed women in 41 of 47 prefectures, with a median sex gap in target probability of 8.0 percentage points and a median lag of 6 years in projected achievement. Conclusions: Based on 2013–2022 trends, Japan is projected to miss the 60% CRC screening target by over a decade. Most prefectures had less than a 5% estimated probability of reaching 60% by 2028, and women lag men by a median of 6 years. Incremental progress under the current system appears insufficient. Reaching the target will require accelerated, prefecture-specific, and sex-sensitive interventions beyond what the current system delivers.
- 27 July 2026
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 31 (10) , 2415-2425
Open AccessForecasting colorectal cancer screening in Japan: regional and sex disparities threaten national targets
Objective: To forecast prefecture-level progress toward Japan's 60% colorectal cancer (CRC) screening target by 2028 and quantify regional and sex-based disparities. Methods: We extracted CRC screening rates (ages 40–69) for all 47 prefectures from 2013 to 2022 using the Comprehensive Survey of Living Conditions. Sex-stratified Bayesian linear regression models were applied to logit-transformed rates. Prefectures were considered likely to achieve the target if the probability of ≥ 60% uptake by 2028 was ≥ 80%. Results: Nationwide coverage is projected to reach 51.9% (95% CrI 44.9–58.8%) by 2028, falling 8.1 percentage points short of the 60% target. Forty of 47 prefectures (85%) had less than a 20% posterior probability of meeting the target, and 14 were projected below 50% coverage. Only Yamagata exceeded the 80% probability threshold for the total population (probability 0.988). For men, three prefectures did (Yamagata, Yamanashi, Miyagi), versus one for women. Men outperformed women in 41 of 47 prefectures, with a median sex gap in target probability of 8.0 percentage points and a median lag of 6 years in projected achievement. Conclusions: Based on 2013–2022 trends, Japan is projected to miss the 60% CRC screening target by over a decade. Most prefectures had less than a 5% estimated probability of reaching 60% by 2028, and women lag men by a median of 6 years. Incremental progress under the current system appears insufficient. Reaching the target will require accelerated, prefecture-specific, and sex-sensitive interventions beyond what the current system delivers.
- 1 May 2026
- Published by Elsevier in Journal of Cancer Policy
- Vol. 48, 100748
Trends and disparities in cervical cancer screening prevalence in Vietnam: Evidence from the 2015 and 2021 WHO STEPS surveys
- 1 May 2026
- Published by Elsevier in Journal of Cancer Policy
- Vol. 48, 100748
Trends and disparities in cervical cancer screening prevalence in Vietnam: Evidence from the 2015 and 2021 WHO STEPS surveys
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S4 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Scenario-specific projections with sensitivity range in 2020–2050, by cancer site, of male 5-year prevalence count Notes: (*) the main projection scenario with the dynamic population demographics, incidence rates, and survival rates; Cancer sites are ordered based on sex-specific prevalence count in year 2020 as reading order, with the highest at the top-left and the lowest at the bottom-right corner.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Scenario-specific projections with sensitivity range in 2020–2050, by cancer site, of male 5-year prevalence count Notes: (*) the main projection scenario with the dynamic population demographics, incidence rates, and survival rates; Cancer sites are ordered based on sex-specific prevalence count in year 2020 as reading order, with the highest at the top-left and the lowest at the bottom-right corner.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S15 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Decomposed absolute changes over 2020–2050 by cancer site, of female 5-year prevalence count Notes: Prevalence in year 2020 is used as reference year; Absolute changes in a specific year X is calculated as Prevalence in year X – Prevalence in reference year. Cancer sites are ordered based on sex-specific prevalence count in year 2020 as reading order, with the highest at the top-left and the lowest at the bottom-right corner.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S15 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Decomposed absolute changes over 2020–2050 by cancer site, of female 5-year prevalence count Notes: Prevalence in year 2020 is used as reference year; Absolute changes in a specific year X is calculated as Prevalence in year X – Prevalence in reference year. Cancer sites are ordered based on sex-specific prevalence count in year 2020 as reading order, with the highest at the top-left and the lowest at the bottom-right corner.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
All-site combined 10-year cancer projections by sex, 2020–2050 Notes: Panel (A): Scenario-specific projections with sensitivity range of prevalence count; (*) the main projection scenario with the dynamic population demographics, incidence rates, and survival rates; the red dashed lines signify the projected peak of prevalence counts (horizontal line) and the corresponding year of the peak (vertical line). Panel (B): Age distribution of cancer survivor. Panel (C): Decomposed absolute changes over 2020–2050 in prevalence count; Absolute changes in a specific year X is calculated as Prevalence in year X – Prevalence in reference year. Prevalence in year 2020 is used as reference year.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
All-site combined 10-year cancer projections by sex, 2020–2050 Notes: Panel (A): Scenario-specific projections with sensitivity range of prevalence count; (*) the main projection scenario with the dynamic population demographics, incidence rates, and survival rates; the red dashed lines signify the projected peak of prevalence counts (horizontal line) and the corresponding year of the peak (vertical line). Panel (B): Age distribution of cancer survivor. Panel (C): Decomposed absolute changes over 2020–2050 in prevalence count; Absolute changes in a specific year X is calculated as Prevalence in year X – Prevalence in reference year. Prevalence in year 2020 is used as reference year.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Table S2 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Sex- and site-specific model validation
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Sex- and site-specific model validation
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S3 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Scenario-specific projections with sensitivity range in 2020–2050, by cancer site, of all-sex 5-year prevalence count Notes: (*) the main projection scenario with the dynamic population demographics, incidence rates, and survival rates; Cancer sites are ordered based on sex-specific prevalence count in year 2020 as reading order, with the highest at the top-left and the lowest at the bottom-right corner.
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Scenario-specific projections with sensitivity range in 2020–2050, by cancer site, of all-sex 5-year prevalence count Notes: (*) the main projection scenario with the dynamic population demographics, incidence rates, and survival rates; Cancer sites are ordered based on sex-specific prevalence count in year 2020 as reading order, with the highest at the top-left and the lowest at the bottom-right corner.
- Open Access
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Table S9 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Site-specific projections of 10-year prevalence count in 2020 and 2050, with decomposition of changes over 2020-2050
- 17 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S9 from Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020–2050: A Statistical Modeling Study
Site-specific projections of 10-year prevalence count in 2020 and 2050, with decomposition of changes over 2020-2050